OverviewSuggest Edit

ZIVO Bioscience, Inc. is dedicated to the study, development, and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. These compounds and mixtures can be extraordinarily complex and dynamic in nature.
In addition to exceptional nutritional qualities, the company's compounds exhibit properties that, properly applied, can yield significant results in supporting a healthy immune response and related metabolic functions, among other beneficial effects.

The ZIVO algae strain provides a sustainable source of protein with a reduced carbon footprint.

TypePublic
Founded1999
HQKeego Harbor, MI, US
Websitezivobioscience.com

Latest Updates

Employees (est.) (Feb 2019)3(+50%)
Revenue (FY, 2020)$20 K
Share Price (Jun 2021)$4.3(-3%)
Cybersecurity ratingBMore

Key People/Management at Zivo Bioscience

Andrew A. Dahl

Andrew A. Dahl

President / Chief Executive Officer & Director
Christopher Maggiore

Christopher Maggiore

Director
Keith Marchiando

Keith Marchiando

Chief Financial Officer
Alison A. Cornell

Alison A. Cornell

Director
Nola E. Masterson

Nola E. Masterson

Director
Casey Fowler

Casey Fowler

Vice-President, Operations and Product Development
Show more

Zivo Bioscience Office Locations

Zivo Bioscience has an office in Keego Harbor
Keego Harbor, MI, US (HQ)
2804 Orchard Lake Rd #202
Show all (1)

Zivo Bioscience Financials and Metrics

Zivo Bioscience Revenue

Zivo Bioscience's revenue was reported to be $20 k in FY, 2020
USD

Revenue (FY, 2020)

20.0k

Net income (FY, 2020)

(9.1m)

EBIT (FY, 2020)

(8.6m)

Market capitalization (4-Jun-2021)

1.8b

Closing stock price (4-Jun-2021)

4.3

Cash (31-Dec-2020)

137.9k

EV

1.8b
Zivo Bioscience's current market capitalization is $1.8 b.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2018FY, 2019FY, 2020

Revenue

88.9k20.0k

Cost of goods sold

138.3k

Gross profit

(49.4k)

Gross profit Margin, %

(56%)
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q4, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

24.1k31.9k20.0k

Cost of goods sold

34.1k25.4k

Gross profit

(10.0k)6.5k

Gross profit Margin, %

(41%)20%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2018FY, 2019FY, 2020

Cash

225.7k47.1k493.1k1.4k16.6k507.0k388.9k346.1k137.9k

Accounts Receivable

118.5k191.0m

Prepaid Expenses

10.4k8.7k72.1k31.7k12.3k22.6k23.3k30.0k

Inventories

Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q4, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

10.3k60.1k132.4k95.6k7.3k25.9k254.6k281.2k96.8k31.0k101.6k11.0k16.0k19.9k259.2k25.7k585.3k1.0m24.2k1.2m317.1k98.1k678.0k228.4k4.3k43.5k15.4k10.0k118.9k

Accounts Receivable

118.5k118.5k118.5k20.0k

Prepaid Expenses

16.5k38.9k37.7k19.4k36.7k87.3k97.4k89.6k37.5k25.1k109.5k47.0k31.9k52.9k33.9k29.3k48.7k33.2k90.8k15.1k89.2k61.7k50.1k99.5k68.7k54.5k148.9k103.8k

Inventories

34.0k15.7k
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2018FY, 2019FY, 2020

Net Income

(2.7m)(3.2m)(10.1m)680.8k(5.8m)(6.1m)(14.6m)(11.5m)(9.1m)

Depreciation and Amortization

967.073.8k19.5k25.0k25.0k25.0k

Inventories

(10.6k)

Accounts Payable

205.0k278.1k(455.4k)744.3k100.1k(448.1k)(119.3k)950.0k187.2k
Quarterly
USDQ2, 2011

Debt/Equity

-0.2 x

Debt/Assets

0.7 x

Financial Leverage

-0.4 x
Show all financial metrics

Zivo Bioscience Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

Zivo Bioscience Online and Social Media Presence

Embed Graph

Zivo Bioscience News and Updates

Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq

KEEGO HARBOR, Mich., May 27, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of nutritional/nutraceutical product candidates originally derived from proprietary algal cultures, today announced the prici…

Zivo Bioscience Frequently Asked Questions

  • When was Zivo Bioscience founded?

    Zivo Bioscience was founded in 1999.

  • Who are Zivo Bioscience key executives?

    Zivo Bioscience's key executives are Andrew A. Dahl, Christopher Maggiore and Keith Marchiando.

  • How many employees does Zivo Bioscience have?

    Zivo Bioscience has 3 employees.

  • What is Zivo Bioscience revenue?

    Latest Zivo Bioscience annual revenue is $20 k.

  • What is Zivo Bioscience revenue per employee?

    Latest Zivo Bioscience revenue per employee is $6.7 k.

  • Who are Zivo Bioscience competitors?

    Competitors of Zivo Bioscience include CustomVite, QRX Pharma and Motion Nutrition.

  • Where is Zivo Bioscience headquarters?

    Zivo Bioscience headquarters is located at 2804 Orchard Lake Rd #202, Keego Harbor.

  • Where are Zivo Bioscience offices?

    Zivo Bioscience has an office in Keego Harbor.

  • How many offices does Zivo Bioscience have?

    Zivo Bioscience has 1 office.